Per-Anders Jansson

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 3

Top Topics

Chronic Kidney Disease

Tyrosine Kinase

Radiofrequency Ablation

Top Venues

Diabetes, obesity & metabolism

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

University of Gothenburg

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Gothenburg

Sweden

Professor

Publications

Vagner Ramon Rodrigues Silva, Angela Molinaro, Andrea Usseglio Gaudi, Emanuel Fryk, Claudia Sardi, Maria E Hammarlund, Filip Mjörnstedt, Maria E Johansson, Barbara Becattini, Per-Anders Jansson, Giovanni Solinas
Somatic ablation of IKKβ in liver and leukocytes is not tolerated in obese mice but hepatic IKKβ deletion improves fatty liver and insulin sensitivity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 (9) (2022)
Isabel Drake, Emanuel Fryk, Lena Strindberg, Annika Lundqvist, Anders H Rosengren, Leif C Groop, Emma Ahlqvist, Jan Borén, Marju Orho-Melander, Per-Anders Jansson
The role of circulating galectin-1 in type 2 diabetes and chronic kidney disease: evidence from cross-sectional, longitudinal and Mendelian randomisation analyses. Diabetologia 65 (1) (2021)
Reza Mobini, Valentina Tremaroli, Marcus Ståhlman, Fredrik Karlsson, Max Levin, Maria Ljungberg, Maja Sohlin, Heléne Bertéus Forslund, Rosie Perkins, Fredrik Bäckhed, Per-Anders Jansson
Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial. Diabetes, obesity & metabolism 19 (4) (2017)